pubmed-article:3437495 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3437495 | lifeskim:mentions | umls-concept:C0036945 | lld:lifeskim |
pubmed-article:3437495 | lifeskim:mentions | umls-concept:C1265549 | lld:lifeskim |
pubmed-article:3437495 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:3437495 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:3437495 | lifeskim:mentions | umls-concept:C0069761 | lld:lifeskim |
pubmed-article:3437495 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3437495 | pubmed:dateCreated | 1988-4-4 | lld:pubmed |
pubmed-article:3437495 | pubmed:abstractText | In goats, there was a linear correlation of area under the plasma concentration-time curve (AUC) with dose in the range 0-20 mg/kg as single dosages of oxfendazole (OFZ). The bioavailability of OFZ after oral administration was lower in goats than in sheep. The repetition of three administrations at 24 h intervals produced significant increase in the AUC in comparison with a single administration equivalent to the total dosage (1 X 5.0 and 3 X 1.7 mg/kg). Infection with O. circumcincta produced a 33% decrease in the bioavailability of OFZ. | lld:pubmed |
pubmed-article:3437495 | pubmed:language | eng | lld:pubmed |
pubmed-article:3437495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3437495 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3437495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3437495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3437495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3437495 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3437495 | pubmed:month | Dec | lld:pubmed |
pubmed-article:3437495 | pubmed:issn | 0140-7783 | lld:pubmed |
pubmed-article:3437495 | pubmed:author | pubmed-author:BoganJJ | lld:pubmed |
pubmed-article:3437495 | pubmed:author | pubmed-author:DelatourPP | lld:pubmed |
pubmed-article:3437495 | pubmed:author | pubmed-author:BenoitEE | lld:pubmed |
pubmed-article:3437495 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3437495 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:3437495 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3437495 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3437495 | pubmed:pagination | 305-9 | lld:pubmed |
pubmed-article:3437495 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:meshHeading | pubmed-meshheading:3437495-... | lld:pubmed |
pubmed-article:3437495 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3437495 | pubmed:articleTitle | Pharmacokinetics of oxfendazole in goats: a comparison with sheep. | lld:pubmed |
pubmed-article:3437495 | pubmed:affiliation | Department of Veterinary Pharmacology, Veterinary School of Glasgow, U.K. | lld:pubmed |
pubmed-article:3437495 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3437495 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:3437495 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |